CClinicalTrials.gg
Not yet recruitingNCT06237543TAPSE/PASPUpdated Feb 1, 2024

TAPSE/PASP Anesthesia

An observational study in Hypotension, sponsored by Aydin Adnan Menderes University. Not yet recruiting at 1 site in Turkey. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2024-02-01.

Sponsored by Aydin Adnan Menderes University · Observational

From the registry’s dates

  • Primary completion was expected by Feb 2025, 1 year 8 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
52
Ages
18 Years to 75 Years
Sex
All
01

Study summary

TAPSE, one of the methods for evaluating right ventricular systolic function; It is a bar parameter that can easily measure apex-basal shortening and provides specific information about global RV function. TAPSE/PASP can be calculated as load-independent parameters to evaluate RV function. Because RV function is sensitive to change in afterload, known as the RV-pulmonary circulation (PC) connection.

This study aims to identify patients who are candidates for hypotensive events due to general anesthesia in a hemodynamically stable population.

Read the detailed description

TAPSE, one of the methods for evaluating right ventricular systolic function; It is a bar parameter that can easily measure apex-basal shortening and provides specific information about global RV function. TAPSE/PASP can be calculated as load-independent parameters to evaluate RV function. Because RV function is sensitive to change in afterload, known as the RV-pulmonary circulation (PC) connection.

This study aims to identify patients who are candidates for hypotensive events due to general anesthesia in a hemodynamically stable population.

Patients will be measured by transthoracic echocardiography in the preoperative period, 15-30 minutes before induction.

Basal hemodynamic parameters and non-invasive and/or hemodynamic values will be recorded every two minutes after induction until surgical incision.Patients with a 30% decrease in SBP from the baseline and a decrease in MAP below 65 mmHg in the first 10 minutes after anesthesia induction will be considered to have hypotension. Patients will be divided into 2 groups: 'with' and 'without' hypotension.

02

Conditions studied

  • Hypotension

Browse trials for

Keywords

  • TAPSE
  • PASP
  • HYPOTENSİON
  • PULMONER RESECTİON
03

In context

Hypotension

1,003 studies on the registry are indexed under Hypotension; 173 are open to participants now.

This study's planned enrollment of 52 is below the median of 84 across 294 observational studies indexed under Hypotension.

Browse Hypotension studies →

Lead sponsor

Aydin Adnan Menderes University is the lead sponsor of 236 studies on the registry; 54 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

ASA1-3 patients aged 18-75 who will undergo pulmonary resection surgery

Inclusion criteria

  1. Written informed consent;
  2. 18-75 years old
  3. ASA Physical Status 1-3;
  4. Patients planned for pulmonary resection surgery

Exclusion criteria

Exclusion Criteria:

  1. The patient is pregnant
  2. After cardiac surgery
  3. Severe pulmonary hypertension
  4. Severe valve disease
  5. Hypertrophic or dilated cardiomyopathy
  6. Presence of acute myocardial infarction
  7. Patients with severe visual or hearing impairment/disability
  8. ASA physical status IV or V
  9. Ischemic heart disease, conduction disorder.
  10. History of long-term use of certain medications (β-blockers, angiotensin converting enzyme inhibitors, analgesics, sedatives or tricyclic antidepressants)
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
52 participants (estimated)
Patient registry
No

Groups and cohorts

  • Hypotension

    Patients with a 30% decrease in SBP from baseline and a decrease in MAP below 65 mmHg in the first 10 minutes after anesthesia induction will be considered to have hypotension.

    Other: hypotension

  • none hypotension

    Patients who do not have a 30% decrease from the baseline in SBP and a decrease in MAP below 65 mmHg in the first 10 minutes after anesthesia induction will be considered as not having hypotension.

Interventions

  • Otherhypotension

    MAP below 55 mmHg or long-term (2 minutes or more) hypotensive attacks will be treated with ephedrine 0.1mg/kg.

    Also known as: treatment

06

What researchers measure

Primary outcomes

  1. echocardiography

    TAPSE/ PASP (mm/mmHg)

    Time frame: 30 minute

Secondary outcomes

  1. tension

    Intraoperative systolic arterial tension, diastolic arterial tension and mean arterial tension will be taken and recorded for the patients.

    Time frame: 4-5 hours

07

Study locations

1 site
  • Ferdi Gülaştı
    Aydın, 09020, Turkey
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 1, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06237543
Lead sponsor
Aydin Adnan Menderes University
Responsible party
ferdi gülaştı (Assistant prof.dr., Aydin Adnan Menderes University) — Principal investigator
First posted
Feb 1, 2024
Start date
Feb 1, 2024 (estimated)
Primary completion
Feb 1, 2025 (estimated)
Completion
Feb 1, 2026 (estimated)
Last update
Feb 1, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion